Bone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy.
about
Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group.Anti-GD2 immunotherapy for neuroblastoma.PHOX2B reliably distinguishes neuroblastoma among small round blue cell tumours.Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F-FDG PET/CT in pediatric patients with neuroblastoma.PCR-based amplification of circulating RNAs as prognostic and predictive biomarkers - Focus on neuroblastoma.Clinical validation of urine 3-methoxytyramine as a biomarker of neuroblastoma and comparison with other catecholamine-related biomarkers.TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients
P2860
Q39041489-80A912EB-3BA7-47EC-BABF-E8877A15714AQ47554435-EBB84857-4668-4404-ABAB-B329BE06F050Q48235413-07C84737-4AB7-495C-A225-FABEE9F99DFAQ50129848-8A029E91-C388-47A3-9A6F-039FAC09391DQ52816741-A3510CD0-3C40-4B65-B32B-11A73C516C1BQ53092963-E621F9D6-5C49-4624-8832-CCF2B4B970EAQ57906738-B5CAF287-07E4-4208-A857-BB5AD687977F
P2860
Bone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Bone marrow minimal residual d ...... after anti-GD2 immunotherapy.
@ast
Bone marrow minimal residual d ...... after anti-GD2 immunotherapy.
@en
type
label
Bone marrow minimal residual d ...... after anti-GD2 immunotherapy.
@ast
Bone marrow minimal residual d ...... after anti-GD2 immunotherapy.
@en
prefLabel
Bone marrow minimal residual d ...... after anti-GD2 immunotherapy.
@ast
Bone marrow minimal residual d ...... after anti-GD2 immunotherapy.
@en
P2093
P2860
P356
P1476
Bone marrow minimal residual d ...... after anti-GD2 immunotherapy.
@en
P2093
Irene Y Cheung
Irina Ostrovnaya
Nai-Kong V Cheung
P2860
P304
P356
10.1200/JCO.2014.57.6777
P407
P50
P577
2015-01-05T00:00:00Z